期刊文献+

霍乱弧菌CTB基因的克隆、表达及重组蛋白活性分析 被引量:1

Cloning and Expression of Vibrio cholerae CTB Gene and the Recombinant CTB Protein Activation Assay
下载PDF
导出
摘要 霍乱弧菌CTB蛋白具有免疫佐剂活性。根据已发表CTB基因的序列设计一对引物,从一株霍乱弧菌中扩增出CTB基因,测序后发现该基因全长375bp,与国内分离的六株CTB基因的同源性达96.0%-99.2%。将该基因与pTWIN1连接构建了原核表达载体pTWIN1-CTB,重组表达载体转化BL21(DE3)表达菌株,0.8mmol/LIPTG诱导4h后,收获的细菌总蛋白SDS—PAGE电泳显示CTB在原核表达系统中得到表达,融合蛋白大小与理论值符合,蛋白产量占细菌总蛋白的20%左右,主要以包涵体形式存在,Western杂交和GM1-ELISA结果表明重组蛋白具有免疫原性和粘膜佐剂活性。 CTB protein possessed mucosal adjuvant immunoactivity. The CTB gene was amplified by PCR method from a strain V. cholerae. The nucleotide sequence of CTB gene was 375 bp and shared 96.0% -99.2% homology with other 6 CTB genes. The recombinant plasmid pTWIN1-CTB transformed E. coli strain BI21 (DE3) expressed with 0. 8 mmol/L IPTG. The molecular weight of expression products was identical with expectative weight by SDS-PAGE electrophoresis. The CTB fusion proteins mainly assembled inclusion bodies and the outputs of proteins were approximately 20% of the total bacterial proteins. The CTB proteins possessed mucosal immunoactivity by GM1-ELISA assay.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2006年第10期13-17,共5页 China Biotechnology
基金 福建省科技厅重点项目(2003N051) 福建省科技厅配套项目(JY0B3020)
关键词 霍乱弧菌CTB基因 原核表达 粘膜佐剂活性 Vibrio Cholerae CTB gene Expression of CTB gene GM1-ELISA
  • 相关文献

参考文献7

  • 1Gill D M,Meren R.ADP-ribosylation of membrane proteins catalyzed by cholera toxin:basis of the activation of adenylate cyclase.Proc Natl Acad Sci USA,1978,75:3050~3054
  • 2江晓玲,贺竹梅,陈清,彭志强,祁瑜,俞守义.霍乱肠毒素B亚单位在转基因番茄果实中特异性表达及其免疫原性的研究[J].中国农业科学,2004,37(8):1188-1192. 被引量:8
  • 3Wu H Y,Russel N W.Induction of mucosal and systemic immune response by intranasal immunization using recombinant cholera B subunit as an adjuvant.Vaccine,1998,16(3):286~ 292
  • 4Sun J B,Holmgren J,Czerkinsky C.Cholera toxin B subunit:An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.Proc Natl Acad Sci USA,1994,91:10795 ~ 10799
  • 5Sambrook J,Fritsch E F,Manjatid T.Molecular cloning:A laboratory Manual.2nd ed,New York:Cold Spring Harbor Laboratory Press,1989
  • 6Czerkinsky C,Russekk M W,Lycke N,et al.Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.Infect Immun,1989,57 (4):1072 ~1078
  • 7夏肖萍,严杰,钊守凤,毛亚飞,李淑萍.大肠杆菌LTB与霍乱弧菌CTB基因的克隆和表达及鉴定[J].浙江大学学报(医学版),2003,32(1):17-20. 被引量:9

二级参考文献28

  • 1[1]Verweij W R, de Haan L, Marijke H, et al. Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen [J]. Vaccine, 1998,16(20):2069-2076.
  • 2[2]Kunio T, Masanori I, Yoko Y, et al. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin [J]. Vaccine, 1997,16(2/3):150-155.
  • 3[3]Yamamoto M, Mcghee J R, Hagiwara Y H, et al. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant [J]. Scand J Immunol, 2001,53(3):211-217.
  • 4[4]de Haan K, Feil I K, Verweij W R, et al. Mutational analysis of the role ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin [J]. Eur J Immunol, 1998,28(4):1243-1250.
  • 5[5]Saito K, Shoji J, Inada N, et al. Immunosuppressive effect of cholera toxin B on allergic conjunctivitis model in guinea pig [J]. Japanese J Ophthamol, 2001,45(4):332-338.
  • 6[6]de Haan L, Verweij W R, Feil I K, et al. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit [J]. Immunology, 1998 Jul,94(3):424-430.
  • 7[7]Sambrook J, Fritsch E F, Maniatis T. Molecular Clo-ning, A Laboratory Manual [M]. 2nd edition. New York: Cold Spring Harbor Laboratory Press, 1989.
  • 8[8]de Haan L, Holtrop M, Verweij W R, et al. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit [J].Vaccine, 1996,14(4):260-266.
  • 9[9]Douce G, Fontana M, Pizza M, et al. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin [J]. Infect Immun, 1997,65(7):2821-2828.
  • 10[10]Yamamoto S, Takeda Y, Yamamoto M, et al. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity [J]. J Exp Med, 1997,185(7):1203-1210.

共引文献15

同被引文献19

  • 1Eriksson K,Holmgren J.Recent advances in mucosal vaccines and adjuvants[J].Current Opinion in Immunology,2002,14:666672.
  • 2Lauterslager T G M,Hilgers L A T.Efficacy of oral administration and oral intake of edible vaccines[J]. Immunology Letters,2002,84:185190.
  • 3Karlsson K A,Tenenberg S,Angstrom J,et al.Unexpected carbohydrate crossbinding by E. coli heatlabile enterotoxin.Recognition of human and rabbit target cell glycoconjugates in comparison with cholera toxin[J]. Bioorganic & Medicinal Chemistry,1996,4:19191928.
  • 4Richards C M,Aman A T,Hirst T R,et al.Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using E. coli heatlabile enterotoxin B subunit as an adjuvant[J].Journal of Virology,2001,75:16641671.
  • 5Millar D G,Hirst T R,Snider D P.Escherichia coli heatlabile enterotoxin B subunit is a more potent mucosal adjuvant than its closely related homologue,the B subunit of cholera toxin[J].Infection and Immunity,2001,69:34763482.
  • 6Verweij W R,de Haan L,Holtrop M,et al.Musosal immunoadjuvant activity of recombinant E. coli heatlabile enterotoxin and its B subunit induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen[J].Vaccine,1998,16:20692076.
  • 7de Haan L,Verweij W R,Holtrop M,et al.Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heatlabile toxin induces IgA or IgGmediated protective mucosal immunity[J].Vaccine,2001,19:28982907.
  • 8Yamanaka H,Ishibashi D,Yamaguchi N,et al.Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heatlabile enterotoxin[J].Vaccine,2006,24:28152823.
  • 9Fingerut E,Gutter B,Meir R,et al.Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast[J].Vaccine,2005,23:46854696.
  • 10Companjen A R,Florack D E A,Slootweg T,et al.Improved uptake of plantderived LTBlinked proteins in carp gut and induction of specific humoral immune responses upon infeed delivery[J].Fish & Shellfish Immunology,2006,21:251260.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部